Hamman-Rich syndrome natural history, complications and prognosis: Difference between revisions
No edit summary |
|||
Line 26: | Line 26: | ||
**[Complication 3] | **[Complication 3] | ||
===Prognosis===<ref name="pmid19095855">{{cite journal |vauthors=Avnon LS, Pikovsky O, Sion-Vardy N, Almog Y |title=Acute interstitial pneumonia-Hamman-Rich syndrome: clinical characteristics and diagnostic and therapeutic considerations |journal=Anesth. Analg. |volume=108 |issue=1 |pages=232–7 |date=January 2009 |pmid=19095855 |doi=10.1213/ane.0b013e318188af7a |url=}}</ref><ref name="pmid17475632">{{cite journal |vauthors=Parambil JG, Myers JL, Aubry MC, Ryu JH |title=Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy |journal=Chest |volume=132 |issue=1 |pages=50–7 |date=July 2007 |pmid=17475632 |doi=10.1378/chest.07-0104 |url=}}</ref> | ===Prognosis=== | ||
*Prognosis of [[Hamman-Rich syndrome|acute interstitial pneumonitis]] is poor.<ref name="pmid19095855">{{cite journal |vauthors=Avnon LS, Pikovsky O, Sion-Vardy N, Almog Y |title=Acute interstitial pneumonia-Hamman-Rich syndrome: clinical characteristics and diagnostic and therapeutic considerations |journal=Anesth. Analg. |volume=108 |issue=1 |pages=232–7 |date=January 2009 |pmid=19095855 |doi=10.1213/ane.0b013e318188af7a |url=}}</ref><ref name="pmid17475632">{{cite journal |vauthors=Parambil JG, Myers JL, Aubry MC, Ryu JH |title=Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy |journal=Chest |volume=132 |issue=1 |pages=50–7 |date=July 2007 |pmid=17475632 |doi=10.1378/chest.07-0104 |url=}}</ref> | |||
*Most patients die because of acute respiratory failure or its complications. | *Most patients die because of acute respiratory failure or its complications. | ||
*Mortality rate is very high, more than half of the patients die within 2 months. Patients who survive the initial hospitalization die within six months of presentation of disease. | *Mortality rate is very high, more than half of the patients die within 2 months. Patients who survive the initial hospitalization die within six months of presentation of disease. | ||
Line 37: | Line 37: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category: Pulmonology]] |
Revision as of 23:47, 24 March 2018
Hamman-Rich syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hamman-Rich syndrome natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Hamman-Rich syndrome natural history, complications and prognosis |
FDA on Hamman-Rich syndrome natural history, complications and prognosis |
CDC on Hamman-Rich syndrome natural history, complications and prognosis |
Hamman-Rich syndrome natural history, complications and prognosis in the news |
Blogs on Hamman-Rich syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis of acute interstitial pneumonitis is poor.[1][2]
- Most patients die because of acute respiratory failure or its complications.
- Mortality rate is very high, more than half of the patients die within 2 months. Patients who survive the initial hospitalization die within six months of presentation of disease.
- Recurrence of the disease and progression to chronic interstitial lung disease can occur among survivors.
References
- ↑ Avnon LS, Pikovsky O, Sion-Vardy N, Almog Y (January 2009). "Acute interstitial pneumonia-Hamman-Rich syndrome: clinical characteristics and diagnostic and therapeutic considerations". Anesth. Analg. 108 (1): 232–7. doi:10.1213/ane.0b013e318188af7a. PMID 19095855.
- ↑ Parambil JG, Myers JL, Aubry MC, Ryu JH (July 2007). "Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy". Chest. 132 (1): 50–7. doi:10.1378/chest.07-0104. PMID 17475632.